Discovery of triazines as selective PDE4B versus PDE4D inhibitors.

Bioorg Med Chem Lett

Tetra Discovery Partners LLC, Grand Rapids, MI, USA; Department of Basic Pharmaceutical Sciences, West Virginia University, Morgantown, WV, USA. Electronic address:

Published: August 2014

In this study we report a series of triazine derivatives that are potent inhibitors of PDE4B. We also provide a series of structure activity relationships that demonstrate the triazine core can be used to generate subtype selective inhibitors of PDE4B versus PDE4D. A high resolution co-crystal structure shows that the inhibitors interact with a C-terminal regulatory helix (CR3) locking the enzyme in an inactive 'closed' conformation. The results show that the compounds interact with both catalytic domain and CR3 residues. This provides the first structure-based approach to engineer PDE4B-selective inhibitors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142572PMC
http://dx.doi.org/10.1016/j.bmcl.2014.06.002DOI Listing

Publication Analysis

Top Keywords

pde4b versus
8
versus pde4d
8
inhibitors pde4b
8
inhibitors
5
discovery triazines
4
triazines selective
4
selective pde4b
4
pde4d inhibitors
4
inhibitors study
4
study report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!